期刊文献+

探测正电子联合OCT杂交探针系统在术中对卵巢恶性病变检测的应用和前景

原文传递
导出
摘要 卵巢癌因其在早期缺乏可靠的症状及有效的筛查技术,患者一经发现多为晚期,在妇科肿瘤中的生存率最低。基因芯片、蛋白质组学和免疫组学等研究方法在卵巢癌早期诊断虽为热点,但尚无确切的定论。所以需要一种敏感度高、具有特异性的方法,对卵巢癌患者做到早诊断、早治疗,提高患者的生活质量。为解决这种情况,一种新型的混合型双模探针已被研发,有研究表明该装置所揭示的结果对卵巢局部高代谢活性的评估及早期恶性病变的检测是有价值的,并且在妇科微创内镜手术中对卵巢的鉴定具有极大的潜力。现就此研究的目前进展做一综述。
出处 《中国优生与遗传杂志》 2013年第3期1-2,22,共3页 Chinese Journal of Birth Health & Heredity
  • 相关文献

参考文献18

  • 1赵霞,钟茜.卵巢癌早期筛查的争议与展望[J].西部医学,2009,21(1):1-2. 被引量:13
  • 2TR Rebbeck, HT Lynch, SL Neuhausen, et al. Prevention and obser- vation of surgical end points study group, prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations [J]. N Engl J Med, 2002, 346(21 ) : 1616 - 1622.
  • 3ND Kanff, JM Satagopan, ME Robson, L Scheuer, et al. Risk -re- ducing salpingo - oophorectomy in women with a BRCA1 or BRCA2 mutation[J]. N Engl J Med, 2002,346(21 ): 1609 - 1615.
  • 4WA Rocca, BR Grossardt, M de Andrade, et al. Survival patterns after oophorectomy in premenopausal women: a population - based cohort study[ J]. Lancet Oncol, 2006, 7 (10) : 821 - 828.
  • 5JS Berek,E Chalas, M Edelson, et al. Berchuck; Society of Gyneco- logic Oncologists Clinical Practice Committee, Prophylactic and risk- reducing bilateral salpingo - oophorectomy: recommendations based on risk of ovarian cancer[ J ]. Obstet Gvnecol, 2010, 116 (3) : 733 - 743.
  • 6Belhocine T, Spaepen K, Dusart M, et al. 18FDG PET in oncology: the best andd the worst [ J ]. Int J Oncol,2006,28 (5) : 1249 - 1261.
  • 7Yen TC, Lai CH. Positron emission tomography in gynecologic cancer [ J ]. Semin Nucl Med ,2006 ,36 ( 1 ) : 93 - 104.
  • 8N Pandit -Taskar. Oncologic imaging in gynecologic malignancies [J]. J Nucl Med, 2005, 46(11): 1842 -1850.
  • 9F Bogalhas, Y Charon, MA Duval, et al. Development of a positron probe for localization and excision of brain tumours during surgery [ J ]. Phys Med Siol, 2009,54 ( 14): 4439 - 4453.
  • 10HW Strauss, C Mari, BE Patt, et al. Intravascular radiation detec- tors for the detection of vulnerable atheroma[ J]. J Am Coll Cardiol, 2006,47(8):97 -100.

二级参考文献9

  • 1Ozols,RF,Bookman,MA,Connolly,DC,Daly,MB,Godwin,AK,Schilder,RJ,Xu,X,Hamilton,TC.Focus on epithelial ovarian cancer[].Cancer Cell.2004
  • 2Sjovall K,Nilsson B,Einhorn N.The significance of serum CA 125 elevation in malignant and nonmalignant diseases[].Gynecologic Oncology.2002
  • 3DePriest P D,DeSimone C P.Ultrasound screening for the early detection of ovarian cancer[].Journal of Clinical Oncology.2003
  • 4Fung M F,Bryson P,Johnston M,et al.Screening postmenopausal women for ovarian cancer: a systematic review[].Journal of Obstetrics and Gynaecology.2004
  • 5Piver MS.Hereditary ovarian cancer Lessons from the first twenty years of the Gilda Radner Familial Ovarian Cancer Registry[].Gynecologic Oncology.2002
  • 6HermsenBB,vonMensdorff-PouillyS,BerkhofJ,etal.SerumCA-125inrelation to adnexal dysplasia and cancer in women at hereditaryhighriskofovariancancer[].Clinical Oncology.2007
  • 7Laframboise-S et al.Use of CA-125 and ultrasound in high-risk women[].International Journal of Gynecological Cancer.2002
  • 8Stirling D,Evans DG,Pichert G,et al.Screening for familialovarian cancer:failure of current protocols to detect ovariancancer at an early stage according to the international Federa-tion of gynecology and obstetrics system[].Journal of Clinical Oncology.2005
  • 9Oei,A.L.,Massuger,L.F.,Bulten,J.Surveillance of women at high risk for hereditary ovarian cancer is inefficient[].British Journal of Cancer.2006

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部